2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one
C31H36N4O2 — CID 15990487
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one
2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one (PubChem CID 15990487) has the molecular formula C31H36N4O2 and a molecular weight of 496.66 g/mol. Its IUPAC name is 2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one.
Molecular Properties
| Compound Name | 2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one |
|---|---|
| PubChem CID | 15990487 |
| Molecular Formula | C31H36N4O2 |
| Molecular Weight | 496.66 g/mol |
| Exact Mass | 496.28 |
| IUPAC Name | 2-cyclohexyl-4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-9-methylpyrido[3,4-b]indol-1-one |
| SMILES | Cc1cccc(N2CCN(C(=O)c3cn(C4CCCCC4)c(=O)c4c3c3ccccc3n4C)CC2)c1C |
| InChI | InChI=1S/C31H36N4O2/c1-21-10-9-15-26(22(21)2)33-16-18-34(19-17-33)30(36)25-20-35(23-11-5-4-6-12-23)31(37)29-28(25)24-13-7-8-14-27(24)32(29)3/h7-10,13-15,20,23H,4-6,11-12,16-19H2,1-3H3 |
| InChIKey | FRMBNJLCXKUHHW-UHFFFAOYSA-N |
| XLogP | 5.58 |
| TPSA | 50.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 496.66 |
| LogP ≤ 5 | 5.58 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15990487 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.